Trinity Biotech (TRIB) Stock Chart & Stock Price History $0.66 +0.00 (+0.74%) As of 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Trinity Biotech Stock Price Performance The Trinity Biotech (TRIB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 76.62%, with a year-to-date return of -22.97%. In the past month, the stock has decreased 10.06%, reflecting recent market activity. As of the latest close, Trinity Biotech traded at $0.66 with a market cap of $11.90 million and volume of 15,213 shares. Five years ago, the stock traded at a split-adjusted price of $9.20, representing a 92.63% decrease over that period. At the time, it had a market cap of $32.94 million and a volume of 191,700 shares. Receive TRIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.51%1 Month Performance-10.06%3 Month Performance-8.13%Year-To-Date Performance-22.97%1 Year Performance-76.62%5 Year Performance-92.63% TRIB Stock Chart for Wednesday, June, 11, 2025 TRIB Chart by TradingView Trinity Biotech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/10/2025$0.65$0.66+0.63%$0.68$0.6615,213 shs$11.90 million06/09/2025$0.66$0.65-0.02%$0.67$0.6224,318 shs$11.82 million06/06/2025$0.64$0.66+2.99%$0.66$0.6428,832 shs$11.83 million06/05/2025$0.65$0.64-2.14%$0.65$0.6313,681 shs$11.48 million06/04/2025$0.64$0.65+2.35%$0.65$0.6422,704 shs$11.73 million06/03/2025$0.66$0.64-3.79%$0.68$0.6337,933 shs$11.46 million06/02/2025$0.63$0.66+4.23%$0.66$0.6336,361 shs$11.92 million05/30/2025$0.64$0.63-1.06%$0.65$0.6373,524 shs$11.43 million05/29/2025$0.63$0.64+0.93%$0.74$0.64102,963 shs$11.56 million05/28/2025$0.67$0.63-5.57%$0.67$0.6364,611 shs$11.45 million Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 05/27/2025$0.69$0.67-3.10%$0.68$0.6540,484 shs$12.12 million05/26/2025$0.69$0.69$0.73$0.6849,587 shs$12.51 million05/23/2025$0.74$0.69-6.35%$0.73$0.6849,587 shs$12.51 million05/22/2025$0.78$0.74-4.66%$0.81$0.7177,729 shs$13.36 million05/21/2025$0.81$0.78-3.82%$0.80$0.7466,565 shs$14.01 million05/20/2025$0.82$0.81-1.59%$0.85$0.7849,843 shs$14.57 million05/19/2025$0.85$0.82-3.21%$0.89$0.8139,717 shs$14.80 million05/16/2025$0.84$0.85+1.32%$0.88$0.7972,029 shs$15.30 million05/15/2025$0.80$0.84+4.53%$0.84$0.8069,951 shs$15.10 million05/14/2025$0.76$0.80+5.76%$0.81$0.74136,568 shs$14.44 million05/13/2025$0.73$0.76+3.60%$0.77$0.7180,983 shs$13.66 million05/12/2025$0.75$0.73-3.14%$0.79$0.72100,393 shs$13.18 million Related Companies Artiva Biotherapeutics Stock Chart PepGen Stock Chart Avalo Therapeutics Stock Chart Century Therapeutics Stock Chart Mersana Therapeutics Stock Chart NRx Pharmaceuticals Stock Chart PMV Pharmaceuticals Stock Chart Akari Therapeutics Stock Chart Connect Biopharma Stock Chart Nabriva Therapeutics Stock Chart Receive TRIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRIB) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
